Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non‐inferiority, phase III trial

Chen, Shaohui; Yuan, Tangmi; Zhang, Jiao; Bai, Hua; Tian, Ming; Pan, Chuxiong; Bao, Hongguang; Jin, Xiaoju; Ji, Fuhai; Zhong, Tai-di; Wang, Qiang; Lv, Jianrui; Wang, Sheng; Li, Yujuan; Yu, Yonghao; Luo, Ailin; Li, Xiang‐Kui; Min, Su; Li, Lin; Zou, Xiaohua; Huang, Yuguang

doi:10.1111/jgh.15188

Public

Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non‐inferiority, phase III trial

Published in Journal of Gastroenterology and Hepatology • Jul 17, 2020

Authors:

Shaohui Chen

Tangmi Yuan

Jiao Zhang

Abstract

BACKGROUND AND AIM: Remimazolam tosilate (RT) is a new short-acting GABA(A) receptor agonist, having potential to be an effective option for procedural sedation. Here, we aimed to compare the efficacy and safety of RT with propofol in patients undergoing upper gastrointestinal endoscopy. METHODS: Th...

Subject

Medicine

Endoscopy

Randomized controlled trial

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!